A record of what Sunil Subramaniam said publicly, with the source. Not advice.
I
Sunil Subramaniam
Track record
Building a track record
Graded calls
0 hit · 0 miss
Pending
1 awaiting resolution
Scored on trackable calls only. Long-horizon and commentary opinions are listed below but not counted in this score.
Recent calls
Newest first. Every call links back to its original source.
| Call | Instrument | Verdict | Actions |
|---|---|---|---|
| “Very bullish on the real estate sector for 2026, despite its past underperformance. Tailwinds include GST cuts on constr…” | Nifty Realty | — | |
| “Anticipates a gradual revival in private capital expenditure as capacity utilisation improves. With top-line growth expe…” | Capital Goods | — | |
| “Bullish on the broader Indian equity market, expecting sustained upside for 2025–26. He believes the rally has just begu…” | Nifty 50 | PENDING | |
| “Bullish on the IT sector, believing the market correction was overdone due to exaggerated fears about H-1B visa caps. He…” | Nifty IT | — | |
| “Bearish on Indian equities if low inflation persists, as it could reduce nominal GDP growth from 10% to 9%, impacting co…” | Indian Equities | — | |
| “Bullish on the Indian market in the near term, expecting it to be relatively insulated from FII selling due to domestic …” | Nifty 50 | — | |
| “Recommends 'Trump-proofing' portfolios by focusing on domestic-oriented sectors like consumption, banking and financial …” | Nifty Financial Services | — | |
| “Bullish on the FMCG pack, viewing it as a safe haven due to its domestic focus, easing commodity prices boosting margins…” | Nifty FMCG | — | |
| “Bullish on the Pharma sector as a defensive play. While past underperformance was due to FII selling and 'Trump effect' …” | Nifty Pharma | — | |
| “Sees continued strength in the capital goods sector, fueled by improving capacity utilization and domestic investor focu…” | Capital Goods Sector | — | |
| “Anticipates market stabilization and a potential IT sector rebound, driven by positive earnings from Wipro and LTIMindtr…” | Nifty IT | — | |
| “Suggests focusing on the IT sector for short-term gains, expecting a continued catch-up rally over the next 18 months. H…” | Nifty IT | — | |
| “Bullish on Indian markets, viewing every dip as a buying opportunity due to strong domestic liquidity, particularly from…” | Nifty 50 | — | |
| “Bearish on the Indian equity market in the near term due to crude oil's surge to $74, which impacts GDP, inflation, and …” | Nifty 50 | — | |
| “Expects continued volatility in the Nifty next week due to geopolitics, but anticipates it will be less severe than the …” | Nifty 50 | — | |
| “Bullish on gold, expecting double-digit returns over the next year. This outlook is driven by ongoing geopolitical tensi…” | Gold | — | |
| “Bullish on gold as an alternative asset, recommending a steady 10-15% allocation at all times. He believes gold is costl…” | Gold | — | |
| “Bullish on private sector banks, favoring them over public sector banks (barring a few large PSBs). He anticipates priva…” | Nifty Private Bank | — | |
| “Bullish on the broad market, recommending gradual accumulation over the next six months due to ongoing volatility but ev…” | Nifty 50 | — | |
| “Bearish on the IT sector, as domestic fund managers are booking profits. This is attributed to the absence of a weaker r…” | Nifty IT | — | |
| “Bullish on the Nifty, noting that it is now trading below its five-year average on valuations, making India no longer ve…” | Nifty 50 | — | |
| “Bullish on private sector banks, viewing them as a 'safety pick' due to valuation comfort, good market share, and growth…” | Nifty Private Bank | — | |
| “Advocates topping up SIPs in mutual funds, especially small and midcap holdings, following a recent 10% market correctio…” | Nifty Midcap 50 | — | |
| “Bullish on the IT sector, expecting benefits from Trumponomics as America cannot yet substitute Indian IT engineers, esp…” | Nifty IT | — | |
| “Bullish on the Pharma sector, seeing a rapid growth opportunity for India due to potential tariffs on Chinese API produc…” | Nifty Pharma | — |
By instrument
Graded calls broken down by what was being called.
Nifty 50
1 pending